Ignite Creation Date:
2024-05-05 @ 6:35 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00509236
Status:
COMPLETED
Last Update Posted:
2017-05-12
First Post:
2007-07-27
Brief Title:
Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and End-Stage Renal Disease MK-0431-073 AM1
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-10-19
Start Date Type:
ACTUAL
Primary Completion Date:
2011-03-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-03-14
Completion Date Type:
ACTUAL
First Submit Date:
2007-07-27
First Submit QC Date:
July 27 2007
Study First Post Date:
2007-07-31
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2012-05-03
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-04-07
Last Update Post Date:
2017-05-12
Last Update Post Date Type:
ACTUAL